BioNTech CEO says new COVID-19 vaccines will likely be needed next year
Why not just make it an annual mandatory thing? Or maybe biannual?
The CEO of BioNTech SE — the German biotechnology company that developed the first COVID-19 vaccine in a partnership with Pfizer — said a new coronavirus vaccine would likely be needed next year.
Ugur Sahin — co-founder and chief executive officer of BioNTech — told the Financial Times on Sunday that a new COVID-19 formula could be necessary by mid-2022 to combat new strains of coronavirus that evade booster shots and the body’s immune defenses. Sahin also stressed that the new vaccine isn’t needed at the moment because he claims that the current COVID-19 vaccine is effective against the delta variant.Recommended VideosPowered by AnyClipRand Paul GRILLS Biden Nominee into Complete Embarrassment on COVID54.8K108Play Video
“This year [a different vaccine] is completely unneeded,” Sahin said. “But by mid next year, it could be a different situation.”